Abstract
Drawing on the concept of vaccine diplomacy, the article analyses Russia’se!orts to promote its Sputnik V vaccine and the repercussions this had intwo Central European EU member states which authorized the use of theRussian vaccine. The authors argue that for Russia, Sputnik V promotionwas significant both as a business project and as a political enterprise, as itwas supposed to enhance Russia’s international status and help it inovercoming its post-Crimea isolation from the West. The results weremixed, however, as Russia’s international credibility had been underminedby its previous policies. Thus, in Hungary the vaccine managed to gainsome traction thanks to a government that preferred importing non-EUcertified vaccines as part of its larger policy of fostering closer ties with theauthoritarian great powers in Eurasia. In Slovakia, the vaccine deal withRussia caused a political crisis but eventually resulted in a very poorperformance of Sputnik V as compared to EU-certified vaccines.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
